US FDA flags shortage of neurosurgical pads and sponges, expects disruption through 2026
May 6 (Reuters) – The U.S. Food and Drug Administration on Wednesday acknowledged ongoing supply disruptions of certain…
This Healthcare Stock Has No Debt and a Near-Monopoly in Its Market
Economic moats can come from different sources. Few are as powerful as a monopoly. Companies with a dominant,…
Amber Therapeutics strengthens its Board and Leadership
Oxford, UK – 24 February 2026 – Amber Therapeutics today announced a series of updates to its business…
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever
Bristol Myers Squibb is a pharmaceutical giant with a solid dividend history. Medtronic is a high-yield medical device…
Commission proposes new measures to improve health and the healthcare sector
The European Commission has put forward a raft of new measures that will improve the health of Europeans…